TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
110,853
|
102,164
|
211,284 |
| Earnings before taxes |
4,231
|
5,883
|
4,812 |
| Total assets |
47,626
|
47,987
|
104,804 |
| Current assets |
45,883
|
45,876
|
50,499 |
| Current liabilities |
24,954
|
29,046
|
29,290 |
| Equity capital |
21,965
|
18,729
|
65,777 |
| - share capital |
536
|
537
|
538 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.1%
|
39.0%
|
62.8% |
| Turnover per employee |
739
|
681
|
1,409 |
| Profit as a percentage of turnover |
3.8%
|
5.8%
|
2.3% |
| Return on assets (ROA) | |||
| Current ratio |
183.9%
|
157.9%
|
172.4% |
| Return on equity (ROE) |
19.3%
|
31.4%
|
7.3% |
| Change turnover |
8,786
|
-108,649
|
112,736 |
| Change turnover % |
9%
|
-52%
|
114% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.